[1]王秋燕 汪妍 郭艺芳.MiR-21在心血管疾病中的研究进展[J].心血管病学进展,2020,(11):1173-1176，1188.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
WANG Qiuyan,WANG Yan,GUO Yifang.Development of miR-21 in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(11):1173-1176，1188.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
点击复制
MiR-21在心血管疾病中的研究进展(
)
《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]
- 卷:
-
- 期数:
-
2020年11期
- 页码:
-
1173-1176，1188
- 栏目:
-
综述
- 出版日期:
-
2020-11-25
文章信息/Info
- Title:
-
Development of miR-21 in Cardiovascular Diseases
- 文章编号:
-
202004017
- 作者:
-
王秋燕 汪妍 郭艺芳
-
(河北省人民医院老年心内科,河北 石家庄050051)
- Author(s):
-
WANG Qiuyan; WANG Yan; GUO Yifang
-
(Department of Geriatric Cardiology, Hebei General Hospital, Shijiazhuang 050051, Hebei, China)
-
- Keywords:
-
miR-21; Coronary atherosclerotic heart disease; Hypertension; Heart failure
- DOI:
-
10.16806/j.cnki.issn.1004-3934.2020.11.000
- Abstract:
-
Cardiovascular disease is a serious threat to human health. MiRNAs are a class of highly conserved non-coding small RNAs. In recent years, miR-21 has been found to be closely related to the cardiovascular system, which is involved in the process of heart development, remodeling, arrhythmia, angiogenesis, angiopathy and so on. This article review the research progress of miR-21 in cardiovascular diseases
备注/Memo
- 备注/Memo:
-
2020-04-0
基金项目：国家自然科学基金青年基金（81700654）；河北省重点研发计划项目（172777169）；河北省重点研发计划项目（19277787D）；河北省创新能力提升计划项目（199776249D）
通信作者：汪妍，E-mail：wy890125fgp@163.com
更新日期/Last Update:
2021-02-04